Michael Kim

Research Assistant Professor

University of Kansas Medical Center

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Michael Kim is a Research Assistant Professor at the University of Kansas Medical Center, USA. His research focuses on therapeutic strategies for respiratory diseases, particularly concerning chronic obstructive pulmonary disease (COPD) and cystic fibrosis (CF). Recent publications explore topics such as ion channel dysfunction, mucociliary function in airway epithelial cells, and the effects of electronic cigarettes on respiratory health.

Articles (11)

Year:

2025

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (4)

Itsaso Garcia-Arcos

Research Assistant Professor

SUNY Downstate Medical Center

UNITED STATES

View details

Jasjit Ahluwalia

Brown University

UNITED STATES

View details

Matthias Salathe

University of Kansas Medical Center

UNITED STATES

View details

Charles Bengtson

Assistant Professor of Medicine

University of Kansas Medical Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Michael Kim

Research Interests

Explore related searches

Contact this professor

About

Articles (11)

Therapeutic strategies to reverse cigarette smoke-induced ion channel and mucociliary dysfunction in COPD airway epithelial cells

E-cigarette aerosols of propylene glycol impair BK channel activity and parameters of mucociliary function

The CFTR Amplifier Nesolicaftor Rescues TGF-β1 Inhibition of Modulator-Corrected F508del CFTR Function

Losartan ameliorates TGF-β1–induced CFTR dysfunction and improves correction by cystic fibrosis modulator therapies

LRP1 loss in airway epithelium exacerbates smoke-induced oxidative damage and airway remodeling

Persistence of airway inflammation in smokers who switch to electronic cigarettes

Is CF airway inflammation still relevant in the era of highly effective modulators?

Vegetable glycerin e-cigarette aerosols cause airway inflammation and ion channel dysfunction

Cystic Fibrosis–related Diabetes Is Associated with Worse Lung Function Trajectory despite Ivacaftor Use

An Open Label Trial to Assess Safety of Losartan for Treating Worsening Respiratory Illness in COVID-19

Hyperglycaemia in cystic fibrosis adversely affects BK channel function critical for mucus clearance

Collaborators (4)

Itsaso Garcia-Arcos

Jasjit Ahluwalia

Matthias Salathe

Charles Bengtson

Make your next move.